JP2014515744A5 - - Google Patents

Download PDF

Info

Publication number
JP2014515744A5
JP2014515744A5 JP2014503978A JP2014503978A JP2014515744A5 JP 2014515744 A5 JP2014515744 A5 JP 2014515744A5 JP 2014503978 A JP2014503978 A JP 2014503978A JP 2014503978 A JP2014503978 A JP 2014503978A JP 2014515744 A5 JP2014515744 A5 JP 2014515744A5
Authority
JP
Japan
Prior art keywords
calcium channel
microparticle
therapeutic agent
sterile
type voltage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014503978A
Other languages
English (en)
Japanese (ja)
Other versions
JP6336899B2 (ja
JP2014515744A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/032317 external-priority patent/WO2012138854A1/en
Publication of JP2014515744A publication Critical patent/JP2014515744A/ja
Publication of JP2014515744A5 publication Critical patent/JP2014515744A5/ja
Application granted granted Critical
Publication of JP6336899B2 publication Critical patent/JP6336899B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014503978A 2011-04-05 2012-04-05 脳血流に影響する脳損傷後の結果を改善するための脳室内ドラッグデリバリーシステム Expired - Fee Related JP6336899B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161471779P 2011-04-05 2011-04-05
US61/471,779 2011-04-05
PCT/US2012/032317 WO2012138854A1 (en) 2011-04-05 2012-04-05 Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016205897A Division JP2017036320A (ja) 2011-04-05 2016-10-20 脳血流に影響する脳損傷後の結果を改善するための脳室内ドラッグデリバリーシステム

Publications (3)

Publication Number Publication Date
JP2014515744A JP2014515744A (ja) 2014-07-03
JP2014515744A5 true JP2014515744A5 (cg-RX-API-DMAC7.html) 2017-01-12
JP6336899B2 JP6336899B2 (ja) 2018-06-06

Family

ID=46969546

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014503978A Expired - Fee Related JP6336899B2 (ja) 2011-04-05 2012-04-05 脳血流に影響する脳損傷後の結果を改善するための脳室内ドラッグデリバリーシステム
JP2016205897A Withdrawn JP2017036320A (ja) 2011-04-05 2016-10-20 脳血流に影響する脳損傷後の結果を改善するための脳室内ドラッグデリバリーシステム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016205897A Withdrawn JP2017036320A (ja) 2011-04-05 2016-10-20 脳血流に影響する脳損傷後の結果を改善するための脳室内ドラッグデリバリーシステム

Country Status (13)

Country Link
US (2) US9364432B2 (cg-RX-API-DMAC7.html)
EP (1) EP2694133B1 (cg-RX-API-DMAC7.html)
JP (2) JP6336899B2 (cg-RX-API-DMAC7.html)
KR (1) KR20140052992A (cg-RX-API-DMAC7.html)
CN (1) CN103517726B (cg-RX-API-DMAC7.html)
AU (1) AU2012240131B2 (cg-RX-API-DMAC7.html)
CA (1) CA2832501A1 (cg-RX-API-DMAC7.html)
GB (1) GB2513675A (cg-RX-API-DMAC7.html)
HK (1) HK1198933A1 (cg-RX-API-DMAC7.html)
IL (1) IL228539B (cg-RX-API-DMAC7.html)
RU (2) RU2606169C2 (cg-RX-API-DMAC7.html)
SG (2) SG10201602665UA (cg-RX-API-DMAC7.html)
WO (1) WO2012138854A1 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10092524B2 (en) * 2008-06-11 2018-10-09 Edge Therapeutics, Inc. Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
AU2012240131B2 (en) * 2011-04-05 2017-07-20 Edge Therapeutics Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow
US9399019B2 (en) * 2012-05-09 2016-07-26 Evonik Corporation Polymorph compositions, methods of making, and uses thereof
EP3682912B1 (en) * 2012-08-17 2025-11-26 AMSilk GmbH Use of self-assembling polypeptides as tissue adhesives
CN103211812A (zh) * 2013-04-02 2013-07-24 苏州大学附属第一医院 Skf96365在治疗蛛网膜下腔出血后发生的脑血管痉挛的应用
RU2741629C2 (ru) 2016-09-20 2021-01-28 Бракко Дайэгностикс Инк. Системы и способы производства, инфузионного ввода и контроля доставки радиоактивного изотопа
US10646227B2 (en) 2016-12-29 2020-05-12 Cerepeutics, LLC Systems and methods for acute treatment to limit intracerebral hemorrhage growth
WO2019018306A1 (en) * 2017-07-17 2019-01-24 Edge Therapeutics, Inc. ADVANCED MICROPARTICULAR FORMULATIONS CONTAINING FORM 2 OF MICRONIZED POLYMORPHIC NIMODIPINE
US20190060109A1 (en) * 2017-08-31 2019-02-28 Gregory Todd Johnson Method of Preventing Traumatic Brain Injury (TBI)
CN112074917B (zh) 2018-03-28 2024-10-29 布拉科诊断公司 用γ检测器对放射性同位素递送系统进行校准的系统和技术
CN112106148B (zh) 2018-03-28 2024-10-29 布拉科诊断公司 放射性同位素发生器寿命的早期检测
CN115104159A (zh) 2020-02-21 2022-09-23 布拉科诊断公司 放射性同位素发生器早期突破检测
US12016774B2 (en) 2020-05-08 2024-06-25 Medtronic Vascular, Inc. Delivery system for prosthetic valve device having controlled release of inflow and outflow ends
RU2763254C1 (ru) * 2020-08-31 2021-12-28 Федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации ФГБОУ ВО ВолгГМУ МЗ РФ Способ лечения церебрального вазоспазма при аневризматическом субарахноидальном кровоизлиянии
US11992642B2 (en) 2020-10-30 2024-05-28 Medtronic, Inc. Implantable medical device for delivery of pharmacological agents to the deep brain structures
US11745003B2 (en) 2020-10-30 2023-09-05 Medtronic, Inc. Implantable access port with one-directional filter
US11931545B2 (en) 2020-10-30 2024-03-19 Medtronic, Inc. Drug infusion port
US12551613B2 (en) 2020-10-30 2026-02-17 Medtronic, Inc. Implantable drug delivery port
US12226609B2 (en) 2020-12-16 2025-02-18 Medtronic, Inc. Method to detect inadvertent delivery of drug to a subcutaneous pocket

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757128A (en) 1986-08-01 1988-07-12 Massachusetts Institute Of Technology High molecular weight polyanhydride and preparation thereof
WO1990013361A1 (en) 1989-05-04 1990-11-15 Southern Research Institute Improved encapsulation process and products therefrom
US5650489A (en) 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
IT1243390B (it) 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
US5399665A (en) 1992-11-05 1995-03-21 Massachusetts Institute Of Technology Biodegradable polymers for cell transplantation
CA2180526A1 (en) 1994-01-05 1995-07-13 Joseph C. Hogan, Jr. Method of identifying chemical compounds having selected properties for a particular application
US5712171A (en) 1995-01-20 1998-01-27 Arqule, Inc. Method of generating a plurality of chemical compounds in a spatially arranged array
US5747058A (en) 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
US5968542A (en) 1995-06-07 1999-10-19 Southern Biosystems, Inc. High viscosity liquid controlled delivery system as a device
AT404429B (de) 1995-06-09 1998-11-25 Immuno Ag Anti-plasma-antikörper-präparation
JP2909418B2 (ja) * 1995-09-18 1999-06-23 株式会社資生堂 薬物の遅延放出型マイクロスフイア
PL189698B1 (pl) 1996-03-12 2005-09-30 Pg Txl Co Kompozycja farmaceutyczna zawierająca lek przeciwnowotworowy i jej zastosowania
ATE318580T1 (de) * 1996-12-20 2006-03-15 Alza Corp Gelzusammensetzungen und verfahren
CA2296056A1 (en) * 1997-07-10 1999-01-21 Keith Baker Methods for universally distributing therapeutic agents to the brain
AU9596698A (en) * 1997-10-15 1999-05-03 Thomas Jefferson University Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal
JP2000070366A (ja) 1998-09-02 2000-03-07 Arute:Kk 容器兼用注射器及び容器兼用注射器への凍結乾燥製剤の封入方法
AU2607701A (en) 1999-12-29 2001-07-09 Regeneration Technologies, Inc. System for reconstituting pastes and methods of using same
JP2003520830A (ja) 2000-01-25 2003-07-08 エドワーズ ライフサイエンシーズ コーポレイション 再狭窄および吻合内膜過形成処置のための送達系
WO2003020208A2 (en) * 2001-08-31 2003-03-13 Neuron Therapeutics, Inc. Treatment of neurologic hemorrhage
US20040235801A1 (en) 2001-10-25 2004-11-25 Jean-Pierre Julien Therapy for stroke
ATE470351T1 (de) 2001-11-22 2010-06-15 Japan Science & Tech Agency Nichtmenschliches tiermodell, das nicht auf eine immunopotenzierende synthetische verbindung anspricht
AU2003219922B2 (en) 2002-02-27 2009-09-10 Pharmain Corporation Compositions for delivery of therapeutics and other materials, and methods of making and using the same
TW200307011A (en) * 2002-04-18 2003-12-01 Chugai Pharmaceutical Co Ltd Hyaluronic acid modifier
DE60334983D1 (de) 2002-04-30 2010-12-30 Bayer Healthcare Llc Faktor vii oder faktor viia polypeptidvarianten
US20060094643A1 (en) 2002-07-03 2006-05-04 Yuri Svirkin Compositions of hyaluronic acid and methods of use
US7713551B2 (en) 2002-09-11 2010-05-11 Elan Pharma International Ltd. Gel stabilized nanoparticulate active agent compositions
JP4092994B2 (ja) 2002-09-13 2008-05-28 ニプロ株式会社 プレフィルドシリンジキット
AU2003298749A1 (en) 2002-11-26 2004-06-18 Seacoast Neuroscience, Inc. Buoyant polymer particles delivering therapeutic agents
WO2005003180A2 (en) 2003-04-10 2005-01-13 Pr Pharmaceuticals A method for the production of emulsion-based micro particles
US20070207211A1 (en) 2003-04-10 2007-09-06 Pr Pharmaceuticals, Inc. Emulsion-based microparticles and methods for the production thereof
AU2004259209A1 (en) 2003-07-23 2005-02-03 Pr Pharmaceuticals, Inc. Controlled release compositions
US9149440B2 (en) * 2003-09-02 2015-10-06 University Of South Florida Nanoparticles for drug-delivery
US20080124400A1 (en) * 2004-06-24 2008-05-29 Angiotech International Ag Microparticles With High Loadings Of A Bioactive Agent
US20060205733A1 (en) 2004-08-26 2006-09-14 Encysive Pharmaceuticals Endothelin a receptor antagonists in combination with phosphodiesterase 5 inhibitors and uses thereof
US8034762B2 (en) * 2004-09-02 2011-10-11 Cognosci, Inc. Treatment of subarachnoid hemorrhage with Apo E analogs
WO2006084005A2 (en) 2005-02-02 2006-08-10 University Of Vermont And State Agricultural College Emergence of a r-type ca2+channel(cav2.3) contributes to cerebral artery constriction following subarachnoid hemorrhage
WO2006091459A2 (en) 2005-02-24 2006-08-31 Joslin Diabetes Center, Inc. Compositions and methods for treating vascular permeability
US20060217340A1 (en) 2005-03-23 2006-09-28 University Of Vermont And State Agricultural College Methods and products for treating hypertension by modulation of TRPC3 channel activity
KR20140014294A (ko) * 2005-03-31 2014-02-05 리드스 에이비 유효 물질의 국소 전달을 기본으로 하는 전립선 질병의 치료 방법
WO2006114105A2 (en) 2005-04-26 2006-11-02 Maxygen Holdings Ltd. Use of modified factor vii for treating bleeding
EA012125B1 (ru) * 2005-05-24 2009-08-28 Утерон Фарма С.А. Двухкамерное смесительное устройство для вязких фармацевтических веществ
US20070042049A1 (en) * 2005-06-03 2007-02-22 Elan Pharma International, Limited Nanoparticulate benidipine compositions
US20090156481A1 (en) 2005-07-15 2009-06-18 Novo Nordisk Healthcare A/G Use of Factor VIIa or Factor VIIa Equivalents for Preventing or Attenuating Haemorrhage Growth, and/or Oedema Generation Following Intracerebral Haemorrhage (ICH) in Patients Treated with Antiplatelet Therapy
US20070203079A1 (en) * 2005-11-21 2007-08-30 Caldwell Guy A Methods of using small molecule compounds for neuroprotection
US9005183B2 (en) * 2007-05-16 2015-04-14 Health Knight, Llc System and method for treating erectile dysfunction
US10092524B2 (en) 2008-06-11 2018-10-09 Edge Therapeutics, Inc. Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
US8252302B2 (en) 2007-06-11 2012-08-28 Edge Therapeutics, Inc. Methods and compositions to treat hemorrhagic conditions of the brain
NZ599430A (en) 2007-06-11 2014-03-28 Loch Macdonald R A drug delivery system for the prevention of cerebral vasospasm
EP2222281B1 (en) 2007-12-20 2018-12-05 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
JP2009067771A (ja) * 2008-05-27 2009-04-02 Pacira Pharmaceuticals Inc 神経学的疾患の治療方法
US20100008968A1 (en) 2008-06-26 2010-01-14 Lampe John W Method for treating cardiovascular diseases using rho kinase inhibitor compounds
EP2331082B1 (en) 2008-09-11 2021-01-06 Evonik Corporation Solvent extraction microencapsulation with tunable extraction rates
CA2737484C (en) 2008-09-18 2017-10-10 Surmodics Pharmaceuticals, Inc. Microencapsulation process with solvent and salt
JP2012515837A (ja) 2009-01-23 2012-07-12 サーモディクス ファーマシューティカルズ, インコーポレイテッド 異なる非反復単位を有するポリマーを含むポリマー混合物、ならびにそれを作製および使用するための方法
US20130059008A1 (en) 2009-01-23 2013-03-07 Jeffrey L. Atkinson Drying methods for tuning microparticle properties
US20100189763A1 (en) 2009-01-23 2010-07-29 Heather Nettles Controlled release systems from polymer blends
US20100291027A1 (en) 2009-05-14 2010-11-18 Jason Campbell Hyaluronic acid (ha) injection vehicle
US20110033463A1 (en) * 2009-08-06 2011-02-10 Medtronic, Inc. Apheresis, administration of agent, or combination thereof
JP5791629B2 (ja) 2009-12-22 2015-10-07 エボニック コーポレイションEvonik Corporation 微粒子を調製する乳剤基調プロセス、及び、プロセスで利用されるワークヘッド構造体
JP2013523752A (ja) 2010-03-29 2013-06-17 エボニック デグサ コーポレイション 局所投与部位における医薬組成物の保持改善のための組成物および方法
PL2658024T3 (pl) * 2011-01-27 2022-12-05 Lg Energy Solution, Ltd. Taśma
AU2012240131B2 (en) * 2011-04-05 2017-07-20 Edge Therapeutics Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow

Similar Documents

Publication Publication Date Title
RU2013148938A (ru) Система интравентрикулярной доставки лекарственного средства для улучшения исхода после повреждения головного мозга, нарушающего мозговое кровообращение
JP5923493B2 (ja) 注射可能なデポー組成物の調製方法
JP5882993B2 (ja) 抗精神病薬デポ型注射用組成物
JP7038741B2 (ja) 放出制御が容易な徐放性薬物微粒子の製造方法
AU2019200649B2 (en) Pharmaceutical formulation comprising an insoluble corticosteroid and a soluble corticosteroid
JP2015522534A5 (cg-RX-API-DMAC7.html)
JP2016512527A5 (cg-RX-API-DMAC7.html)
RU2015143206A (ru) Композиции и их применение для лечения осложнений аневризматического субарахноидального кровоизлияния
US20200246470A1 (en) Microparticles containing finasteride and preparation method thereof
JP2014516080A5 (cg-RX-API-DMAC7.html)
JP6728221B2 (ja) 長時間作用型注射可能パリペリドンエステルの抜かした投与量のための投与レジメン
EP1994925A1 (en) Taxane pharmaceutical formulation, solid taxane composition, method for preparing the solid taxane composition, composition for solubilising said solid taxane composition and set of elements (kit) for the injectable taxane formulation
WO2015141662A1 (ja) 固体分散体
RU2014149362A (ru) Полиморфные композиции, способы их получения и применение
Etminan et al. Intrathecal application of the nimodipine slow-release microparticle system eg-1962 for prevention of delayed cerebral ischemia and improvement of outcome after aneurysmal subarachnoid hemorrhage
KR20100017904A (ko) 마이크로입자 중에 소마토스타틴 유도체를 포함하는 연장-방출 조성물
JP2022188127A (ja) 注射可能な懸濁液
TW202302117A (zh) 低吸附格列本脲調配物及方法
KR102363727B1 (ko) 생체이용률이 개선된 프란루카스트 함유 고형 제제의 조성물 및 그 제조방법
KR20180115750A (ko) 치료 입자를 동결건조시키기 위한 안정한 제제
JP2014509318A5 (cg-RX-API-DMAC7.html)
CA3233139A1 (en) Pharmaceutical formulation comprising tacrolimus, method for the preparation thereof and use
TW201720447A (zh) 裝載活性成份之奈米粒子、彼等之製法及用途
US8734852B2 (en) Parenteral controlled release formulations of NSAID's
AU2021201165A1 (en) Controlled release compositions and their methods of use